Presentation is loading. Please wait.

Presentation is loading. Please wait.

Parenteral Nutrition.

Similar presentations


Presentation on theme: "Parenteral Nutrition."— Presentation transcript:

1 Parenteral Nutrition

2 NUTRITION Human nutrition is the provision to obtain the essential nutrients necessary to support life and health Nutrients are the substances that are not synthesized in sufficient quantity in the body and therefore must be supplied from diet Macronutrients mainly carbohydrates, fats, protein, dietary fiber and water Micronutrients: vitamins, minerals and trace elements

3 Essential Nutrients Protein (Amino acids) Fat Carbohydrate
Dietary fiber Water and electrolytes Vitamins minerals Trace elements

4 ENTERAL NUTRITION Refers to feeding via a tube placed into the gut to deliver liquid formulas containing all essential nutrients Preferred route because of benefits derived from maintaining the digestive, absorptive and immunological barrier function of GIT Enteral/tube feeding is useful in pts who have functional GIT, but who cannot digest or ingest adequate amount of nutrients Short term (<6 weeks) tube feeding can be achieved by nasogastric, nasoduodenal or nasojejunal tubes

5 ENTERAL Vs PARENTERAL Enteral nutrition is associated with fewer complications than parenteral nutrition and is less expensive to administer. However, the use of enteral nutrition alone often does not achieve caloric targets. In addition, underfeeding is associated with weakness, infection, increased duration of mechanical ventilation, increased duration of hospital stay and death. Combining parenteral nutrition with enteral nutrition constitutes a strategy to prevent nutritional deficit but may risk overfeeding which has been associated with liver dysfunction, infection, and prolonged ventilatory support.

6 PARENTERAL NUTRITION The consequences of major surgeries and PEM can lead to hypermetabolism and subsequent malnutrition. A strong association exist between malnutrition and increased post operative morbidity and mortality. The administration of TPN can prevent the effects of starvation in pts with non functional GIT Parenteral nutrition should be considered if energy intake has been inadequate for more than days and enteral feeding is not feasible. (based on ICU focused meta- analysis discussed in 2009 ASPEN)

7 Parenteral nutrition It involves the continuous infusion of a hyperosmolar solution containing carbohydrates, proteins, fat and other necessary electrolytes through an indwelling catheter inserted into (usually) SVC to meet the nutritional needs of the patient. PN through a peripheral vein is limited by osmolality and volume constraints Solutions that contain more than 3% aminoacid and 5% glucose are poorly tolerated peripherally

8 Types Peripheral parenteral nutrition (PPN)
administered through a peripheral intravenous catheter. The osmolarity of PPN solutions generally is limited to 1,000 mOsm (approximately 12% dextrose solution) to avoid phlebitis. Thus, large volumes (>2,500 mL) are needed. Temporary nutritional supplementation with PPN may be useful Generally intended as supplement to oral feeding and is not optimal for critically ill pts

9 Total parenteral nutrition (TPN)
provides complete nutritional support The solution, volume of administration, and additives are individualized based on an assessment of the nutritional requirements.

10 Types of TPN formulations
TPN formulation without lipid (2-in-1 solution) Calories from amino acids- 20 to 25% Calories from dextrose % TPN formulation with lipid ( 3-in-1 solution) calories from amino acids- 20 to 25% calories from lipids- 20% calories from dextrose- 55 to 60 %

11 Special solutions that contain low, intermediate, or high nitrogen concentrations as well as varying amounts of fat and carbohydrate are available for pts with diabetes, renal or pulmonary failure, or hepatic dysfunction.

12 Additives: Electrolytes (i.e., sodium, potassium, chloride, acetate, calcium, magnesium, phosphate) should be adjusted daily. The number of cations and anions must balance; this is achieved by altering the concentrations of chloride and acetate. If the serum bicarbonate is low, the solution should contain more acetate. The calcium:phosphate ratio must be monitored to prevent salt precipitation.

13 Medications: Albumin, H2-receptor antagonists, heparin, iron, dextran, insulin, and metoclopramide can be administered in TPN solutions. However, not all medications are compatible with 3-in-1 admixtures. Regular insulin should initially be administered subcutaneously according to a sliding scale, based on a determination of the blood glucose level. After a stable insulin requirement has been established, insulin can be administered in the TPN solution, generally at two thirds of the daily subcutaneous insulin dose.

14 TPN- macronutrient solutions
Crystalline amino acid solutions containing % essential and 50-60% non essential amino acids are used to provide protein needs Some amino acid solutions have been modified: rich in branched chain amino acids for hepatic encephalopathy, rich in essential amino acid for renal insufficiency pts Glucose in IV solutions is hydrated; each gm of dextrose monohydrate provides 3.4 kcal. While there is no absolute requirement of glucose in most pts, providing >150g glucose/d maximizes protein balance

15 TPN- macronutrient solutions
Lipid emulsions are available as 10% (1.1kcal/ml) or 20% (2 kcal/ml) solutions and provide energy as well as source of essential fatty acids. Rate of infusion should not exceed 1 kcal/kg/h

16 Some commercial available formulations
Climomel N5-800 Clinimix N9G-20E Kabiven Vitrimix Celemix-G

17 Indications gastrointestinal cutaneous fistula Renal failure (ATN)
Short bowel syndrome Severe burns Hepatic failure Crohn’s disease Anorexia nervosa Acute radiation enteritis Acute chemotherapy toxicity Prolonged ileus Weight loss preliminary to major surgery

18 ADMINISTRATION OF TPN Introduction of TPN should be gradual. For example, approximately 1,000 kcal is provided the first day. If there is metabolic stability (i.e., normoglycemia), this is increased to the caloric goal over 1 to 2 days. TPN solutions are delivered most commonly as a continuous infusion. A new 3-in-1 admixture bag of TPN is administered daily at a constant infusion rate over 24 hours. Additional maintenance intravenous fluids are unnecessary, and total infused volume should be kept constant while nutritional content is increased.

19 Cyclic Administration
Cyclic administration of TPN solutions may be useful for (1) those who will be discharged from the hospital and subsequently receive home TPN, (2) those with limited intravenous access who require administration of other medications, and (3) those who are metabolically stable and desire a period during the day when they can be free of an infusion pump. Cyclic TPN is administered for 8 to 16 hours, most commonly at night. This should not be done until metabolic stability has been demonstrated for patients on standard, continuous TPN infusions.

20

21 ROUTES OF TPN: Central TPN: (usual osmolarity = 2000 mosmol/L)
Advantages Can provide full nutritional support (No limits in concentration of dextrose and amino acids) No risk of thrombophlebitis No risk of edema No pain Disadvantages Requires surgery More risk of sepsis than peripheral TPN High risk of mechanical complications

22 Peripheral TPN: (maximum osmolarity in neonates = 1100/L,
Pediatrics = 1000/L, Adults = 900/L) Advantages Does not require surgery Less risk of sepsis than central TPN No risk of mechanical complications Disadvantages High risk of thrombophlebitis Painful, and chance of edema Does not require full nutrition support. Needs more fluids to provide more nutrition. (maximum dextrose = 7.5% and AA = 2.5%)

23 Monitoring of parenteral nutrition

24

25

26 Complications Of TPN Mechanical metabolic infectious

27 Mechanical Complications
Air embolism pneumothorax hemothorax Cardiac tamponade Injuries to arteries and veins Injury to thoracic duct Brachial plexus injury

28 Metabolic complications
Early or nutrient related hyperglycemia hypoglycemia hyperlipidemia refeeding syndrome late or related to long term administration hepatic dysfunction Steatosis, steatohepatitis, lipidosis, cholestasis, cirrhosis biliary complications: acalculous cholecystitis, Gb sludge, cholelithiasis Metabolic bone disease: osteomalaacia, osteopenia

29 Fluid overload Hypo/hypernatremia Hypercalcemia Hypo/hyperkalemia Infection : Catheter related sepsis is most common life threatening complication Causes: staph epidermidis and staph aureus, enterococcus, candida, E coli, psuedomonas, klebsiella etc in immunocompromised pts

30 Refeeding syndrome Severe electrolyte and fluid shifts that may result from refeeding after severe weight loss (PEM) Hypophosphatemia is the hallmark of refeeding syndrome due to shift from fat to glucose metabolism. Hypokalemia and hypomagnesemia ↓K and ↓PO4→ ATP deficiency which can be life threatening.

31 Care of the parenteral nutrition (PN) mixture
Store reconstituted PN bags in a refrigerator until use Always use aseptic techniques while connecting and infusing PN Always use an infusion set with in-built air vent and 0.2 m filter Never insert a needle for air venting in a PN bag Never add any medication to the PN bag Avoid frequent changes in the formulation of the PN solution Infuse the prescribed volume and avoid wastage of PN solution


Download ppt "Parenteral Nutrition."

Similar presentations


Ads by Google